Day: March 16, 2020

CALGARY, Alberta, March 16, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, with late stage clinical programs, is re-issuing its earlier press release with a clarified title pursuant to the Company’s announcement that it is exploring the potential of using XRx-101 (a new formulation of Oxypurinol) as a novel treatment for acute kidney and lung injury accompanying Coronavirus infection and specifically for the COVID-19 infection. The Company has reviewed recent studies characterizing the outbreak of COVID-19 in mainland China. These published reports clearly illustrate that acute kidney injury and acute pulmonary injury are key factors in the most serious cases...

Selskabsmeddelelse 22/2020)Finansmarkederne er fortsat påvirkede af usikkerhed som følge af Coronavirus. Det er vores vurdering, at usikkerheden om prisstillelsen er reduceret. Vi anmoder derfor om ophævelse af suspensionen for samtlige afdelinger.Med venlig hilsenSyd Fund Management A/STlf. 74 37 33 00

Investeringsforeningen Sydinvest, anmoder om ophør af suspension i afdelinger.

AS PRFoods  (hereinafter “PRFoods”) hereby announces that on 16 March 2020, the Estonian Financial Supervision Authority (hereinafter the “EFSA”) registered a supplement (hereinafter the “Prospectus Supplement”) to the prospectus (hereinafter the “Prospectus”) prepared by PRFoods and approved by the EFSA on 9 March 2020, in relation the public offering (hereinafter the “Offering”) and listing (hereinafter the “Listing”) of secured notes of PRFoods, with the nominal value of EUR 100 per note, interest rate of 6.25% per annum and maturity date on 22 January 2025 (hereinafter the “Notes”).The Prospectus Supplement was prepared to: (i) set out an additional risk factor specifically relating to the severe acute respiratory syndrome coronavirus 2 (commonly known as SARS-CoV-2) and the infectious disease COVID-19, caused by the virus; and (ii)...

AS PRFoods  (edaspidi „PRFoods“) teavitab käesolevaga, et 16. märtsil 2020. a registreeris Finantsinspektsioon (edaspidi „FI“) lisa (edaspidi „Prospekti Lisa“) PRFoods’i poolt koostatud ning FI poolt 9. märtsil 2020. a registreeritud PRFoods’i tagatud võlakirjade, nimiväärtusega 100 eurot võlakirja kohta, intressimääraga 6,25% aastas ja lunastustähtajaga 22. jaanuar 2025. a (edaspidi „Võlakirjad“) avaliku pakkumise (edaspidi „Pakkumine“) ja noteerimise (edaspidi „Noteerimine“) prospektile (edaspidi „Prospekt“).Prospekti Lisa koostati, et: (i) tuua välja täiendav riskifaktor, mis puudutab spetsiifiliselt koroonaviirust SARS-CoV-2 (severe acute respiratory syndrome coronavirus) ning selle poolt põhjustatavat nakkushaigust COVID-19; ja (ii) pikendada tulenevalt suurenenud volatiilsusest finantsturgudel Pakkumise perioodi (edaspidi „Pakkumisperiood“)...

Šiaulių Bankas AB (hereinafter the Bank), company code 112025254, registered address Tilžės g. 149, Šiauliai, Lithuania.The Bank announced the General Meeting of Shareholders convened on March 31, 2020: https://cns.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=925772&messageId=1166561  (Notification 1) and announced the draft decisions of the Board of the Bank for agenda items: https://cns.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=925780&messageId=1166569 (Notification  2).Taking into account the quarantine regime established from 16/03/2020 to 30/03/2020 by Resolution No. 207 of the Government of the Republic of Lithuania,  the Board of the Bank during its meeting on 16 March 2020 decided to:1.  Change the venue of the General Meeting of Shareholders:     a. previously announced meeting place – auditorium...

AB Šiaulių bankas (toliau Bankas), įmonės kodas 112025254, buveinės adresas Tilžės g. 149, Šiauliai, Lietuva.Bankas 2020-03-09 pranešė apie 2020-03-31 šaukiamą visuotinį akcininkų susirinkimą: https://cns.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=925772&messageId=1166560 (1 pranešimas) ir paskelbė Banko valdybos sprendimų projektus susirinkimo darbotvarkės klausimais: https://cns.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=925780&messageId=1166570 (2 pranešimas).Banko valdyba, įvertinusi Lietuvos Respublikos vyriausybės 2020-03-14 nutarimu Nr. 207 nuo 2020-03-16 00:00 iki 2020-03-30 24:00 įvestą karantino režimą,  2020 m. kovo 16 d. posėdyje nusprendė:Pakeisti visuotinio akcininkų susirinkimo vietą:anksčiau skelbta susirinkimo vieta – Šiaulių J. Janonio gimnazijos aktų salė, Tilžės g. 137, Šiauliai.pakeista...

Pressmeddelande 2020-03-16Den 12 mars genomförde Erik Penser Bank en bolagsdag med ArcAroma som ett av de medverkande bolagen. ArcAromas VD, Johan Möllerström, genomförde en bolagspresentation och en intervju under dagen. Båda aktiviteterna filmades och finns nu publicerade på ArcAromas hemsida www.arcaroma.com.Se presentationen från Erik Penser Banks Bolagsdag samt intervjun med Johan Möllerström här:Till ArcAromas presentation från bolagsdagenTill intervjun med Johan MöllerströmFör ytterligare information, vänligen kontakta:Johan Möllerström, CEO(+46) 768 – 86 81 78johan.mollerstrom@arcaroma.comOm ArcAroma AB (publ)ArcAroma har utvecklat ett sätt att kontrollera och applicera elektriska pulser för att optimera olika biologiska processer. CEPT®-plattformen, som är en generator kombinerad med behandlingskammare, använder tekniken för livsmedelsutvinning,...

Grundet den fortsatte uro på markederne i forbindelse med COVID-19 krisen har Nykredit Portefølje Administration A/S anmodet Nasdaq Copenhagen om suspension af fonde, som administreres af Nykredit Portefølje Administration A/S.Suspensionen vil blive ophævet, når det er muligt at stille korrekte priser.Følgende fonde er omhandlet:Eventuelle spørgsmål til denne meddelelse kan rettes til direktør Martin Udbye Madsen, tlf. 44 55 92 00.Med venlig hilsenNykredit Portefølje Administration A/SMartin Udbye Madsen, adm. direktørVedhæftet filSuspension_16_03_2020_nr_2